Should a QP audit CROs and Investigators?
Recommendation

Thursday, 29 October 2026 9 .00 - 17.15 h
AI/ML-based Methods for Optimizing Pharmaceutical Research Processes
As third set in row of Q&A documents, the European QP Association has published a Q&A document on IMP-related questions.
The new set of questions (on the European QP Association website) is dealing with topics like:
- Completeness of the IMPD
- Reanalysis of IMPs
- Audits
- Contracts
Related GMP News
11.06.2026In-use Storage Time of Reconstituted Medicines
11.06.2026Pilot on Real-Time Clinical Trials
28.05.2026New EMA Q&A on the Implementation of 3DP Technology
28.05.2026EMA publishes Presentations on Contractual Agreements in Clinical Trials
28.05.2026UK Substantial Modifications Pilot
07.05.2026What are the GMP Requirements for Investigational Medicinal Products (IMPs)?

